Subscribe

What are you looking for?

Main Menu

明報新聞網

中生製藥上半年多賺1.4倍至34億人幣 中期息增逾六成至5港仙

Future Wealths
Future Wealths
18 8 月, 2025
One Min Read
6 Views
0 Comments
中國生物製藥（1177）公布6月底止中期業績，持續業務股東應佔溢利達33.9億元（人民幣、下同），按年增長1.4倍；基本溢利達30.9億元，按年升1.01倍；每股中期息0.05港元，按年增66.67%。

原文: https://finance.mingpao.com/fin/instantf/20250818/1755507909783/%E4%B8%AD%E7%94%9F%E8%A3%BD%E8%97%A5%E4%B8%8A%E5%8D%8A%E5%B9%B4%E5%A4%9A%E8%B3%BA1-4%E5%80%8D%E8%87%B334%E5%84%84%E4%BA%BA%E5%B9%A3-%E4%B8%AD%E6%9C%9F%E6%81%AF%E5%A2%9E%E9%80%BE%E5%85%AD%E6%88%90%E8%87%B35%E6%B8%AF%E4%BB%99%22%20target=%22blank

Last Update: 18 8 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept